We are live on ! Find out more
CL

Choreo LLC Portfolio holdings

AUM $8.15B
1-Year Est. Return 20.12%
This Fund
S&P 500
This Quarter Est. Return
+7.24%
1 Year Est. Return
+20.12%
3 Year Est. Return
+59.68%
5 Year Est. Return
+57.89%
10 Year Est. Return
+205.42%
AUM
$6.82B
AUM Growth
+$857M
Cap. Flow
+$521M
Cap. Flow %
7.64%
Top 10 Hldgs %
28.83%
Holding
1,708
New
192
Increased
931
Reduced
413
Closed
80

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$5.22M
2
LRCX icon
Lam Research
LRCX
+$3.85M
3
BLK icon
Blackrock
BLK
+$3.83M
4
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$3.4M
5
TFC icon
Truist Financial
TFC
+$2.51M

Sector Composition

Rank Sector Weight
1 Technology 12.98%
2 Financials 8.42%
3 Consumer Discretionary 4.66%
4 Healthcare 4.16%
5 Industrials 4.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDY icon
201
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$4.56M 0.07%
8,075
-583
-7% -$321K
TMUS icon
202
T-Mobile US
TMUS
$193B
$4.53M 0.07%
21,980
+3,692
+20% +$707K
TJX icon
203
TJX Companies
TJX
$170B
$4.45M 0.07%
38,117
+2,492
+7% +$286K
MDT icon
204
Medtronic
MDT
$107B
$4.44M 0.07%
49,018
+1,475
+3% +$124K
BIL icon
205
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
$4.38M 0.06%
47,664
+53
+0.1% +$4.86K
PANW icon
206
Palo Alto Networks
PANW
$264B
$4.37M 0.06%
26,540
+3,342
+14% +$563K
BA icon
207
Boeing
BA
$165B
$4.35M 0.06%
28,176
+2,526
+10% +$433K
CVS icon
208
CVS Health
CVS
$137B
$4.3M 0.06%
69,936
+6,106
+10% +$356K
USB icon
209
US Bancorp
USB
$99.6B
$4.3M 0.06%
95,670
+2,355
+3% +$103K
VOE icon
210
Vanguard Mid-Cap Value ETF
VOE
$23.7B
$4.28M 0.06%
25,633
+426
+2% +$67.7K
SCHG icon
211
Schwab US Large-Cap Growth ETF
SCHG
$58.5B
$4.28M 0.06%
166,644
+4,744
+3% +$119K
CI icon
212
Cigna
CI
$76.6B
$4.26M 0.06%
12,241
+1,435
+13% +$494K
ADI icon
213
Analog Devices
ADI
$181B
$4.25M 0.06%
18,981
+1,564
+9% +$352K
REGN icon
214
Regeneron Pharmaceuticals
REGN
$68.8B
$4.22M 0.06%
4,035
+250
+7% +$278K
SNY icon
215
Sanofi
SNY
$104B
$4.12M 0.06%
71,807
+15,833
+28% +$855K
AZN icon
216
AstraZeneca
AZN
$263B
$4.09M 0.06%
26,021
+2,078
+9% +$335K
WWD icon
217
Woodward
WWD
$25B
$4.09M 0.06%
24,163
+659
+3% +$110K
XLK icon
218
State Street Technology Select Sector SPDR ETF
XLK
$115B
$4.05M 0.06%
36,816
+5,142
+16% +$564K
QQEW icon
219
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.71B
$4.01M 0.06%
32,355
-4,007
-11% -$491K
SO icon
220
Southern Company
SO
$110B
$3.99M 0.06%
43,921
+3,844
+10% +$328K
MO icon
221
Altria Group
MO
$122B
$3.97M 0.06%
76,618
+8,118
+12% +$410K
PDX
222
PIMCO Dynamic Income Strategy Fund
PDX
$957M
$3.9M 0.06%
165,191
+3,759
+2% +$86.4K
DHI icon
223
D.R. Horton
DHI
$41.2B
$3.89M 0.06%
20,185
+1,280
+7% +$225K
CB icon
224
Chubb
CB
$140B
$3.82M 0.06%
13,043
+690
+6% +$189K
GLD icon
225
SPDR Gold Trust
GLD
$131B
$3.8M 0.06%
15,487
-1,603
-9% -$367K

Similar funds

Choreo LLC's Q3 2024 Portfolio in Review

As of Q3 2024, Choreo LLC held 1,708 positions worth $6.82B, up 14% from $5.96B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Choreo LLC deployed $521M of net new capital in Q3 2024, opening 192 new positions and adding to 931 existing holdings. Its largest new stake was MACOM Technology Solutions: 600,230 shares worth $64.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Blackstone, an estimated $5.22M trimmed.

  • Choreo LLC's largest Q3 2024 buy was MACOM Technology Solutions: 600,230 shares worth $64.2M.
  • Choreo LLC added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $43.6M increase.
  • Choreo LLC's biggest Q3 2024 reduction was Blackstone, cutting an estimated $5.22M.
  • Choreo LLC fully exited Lam Research in Q3 2024, selling an estimated $3.85M.
  • Choreo LLC's ten largest holdings make up 29% of its $6.82B portfolio in Q3 2024.
  • Choreo LLC opened 192 new positions and closed 80 in Q3 2024.
  • Choreo LLC's portfolio value rose 14% quarter-over-quarter to $6.82B.

Based on Choreo LLC's 13F filing for Q3 2024, filed 7 Nov 2024.